Orphazyme A/S
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is the Arimoclomol, which is in clinical development for diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, and Inclusion Body Myositis. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Show More...
-
Website https://www.orphazyme.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 850.00 DKK
-
Last Updated 23-12-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share DKK -4.66 -5.89 -10.43 -11.49 -16.87 -16.87 Dividends DKK Payout Ratio % * Shares Mil 10.0 10.0 12.0 20.0 20.0 20.0 Book Value Per Share * DKK 6.09 25.53 11.25 1.96 Free Cash Flow Per Share * DKK -7.22 -8.51 -14.34 Return on Assets % -56.17 -99.12 -36.33 -41.59 -108.5 -108.5 Financial Leverage (Average) 1.15 1.82 1.08 1.14 3.41 3.41 Return on Equity % -64.35 -126.42 -39.86 -45.74 -152.98 -152.98 Return on Invested Capital % -64.35 -126.29 -39.67 -45.07 -111.88 -111.88 Interest Coverage -892.45 -202.56 -67.09 -70.41 -70.41 Current Ratio 7.45 1.93 13.75 7.99 2.25 2.25 Quick Ratio 6.35 1.23 13.64 7.47 1.9 1.9 Debt/Equity 1.16 1.16